Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
Genes, Chromosomes & Cancer|April 29, 2014
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasmsDarko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Scientific Reports|July 18, 2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1Nicole Naumann, Vito Dangelo, Johannes Lübke, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2021
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative networkVivien Schäfer, Helen E White, Gareth Gerrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|April 28, 2009
Frequent upregulation of MYC in plasma cell leukemiaLaura Chiecchio, Gian Paolo Dagrada, Helen E White, et al.
Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.
Annals of Hematology|September 28, 2014
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genesJuliana Schwaab, Marcin Knut, Claudia Haferlach, et al.
British Journal of Haematology|August 1, 2020
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemiaGraeme Smith, Jane Apperley, Dragana Milojkovic, et al.
Blood|October 4, 2019
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinibJennifer M O'Sullivan, Angela Hamblin, Christina Yap, et al.
Genes, Chromosomes & Cancer|January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemiaAndreas Reiter, Susanne Saussele, David Grimwade, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Genes, Chromosomes & Cancer|April 29, 2014
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasmsDarko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Scientific Reports|July 18, 2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1Nicole Naumann, Vito Dangelo, Johannes Lübke, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2021
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative networkVivien Schäfer, Helen E White, Gareth Gerrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|April 28, 2009
Frequent upregulation of MYC in plasma cell leukemiaLaura Chiecchio, Gian Paolo Dagrada, Helen E White, et al.
Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.
Annals of Hematology|September 28, 2014
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genesJuliana Schwaab, Marcin Knut, Claudia Haferlach, et al.
British Journal of Haematology|August 1, 2020
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemiaGraeme Smith, Jane Apperley, Dragana Milojkovic, et al.
Blood|October 4, 2019
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinibJennifer M O'Sullivan, Angela Hamblin, Christina Yap, et al.
Genes, Chromosomes & Cancer|January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemiaAndreas Reiter, Susanne Saussele, David Grimwade, et al.
Pageof 23